BIOMOL INTERNATIONAL search BIOMOL International MYC products
includes other brands or spellings
|
| wb | | Biomol anti-Myc antibody was used in western blot to study Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. |
| wb | | BIOMOL Research Laboratories anti-c-Myc antibody (9E10) was used in western blot to study the aberrant localization of ß-catenin correlated with overexpression of its target gene in human papillary thyroid cancer. |
CELL SIGNALING TECHNOLOGY search Cell Signaling Technology MYC products
includes other brands or spellings
|
| ic | | Cell Signaling anti-Myc monoclonal or polyclonal antibodies were used in immunocytochemistry to study lysosomal BACE degradation. |
| wb | | Cell Signaling antibody specific for the Myc phospho-Thr-58/Ser-68 domain was used in western blot to human papillomavirus E6 association with Myc proteins in vivo, binding to and cooperatively activating the telomerase reverse transcriptase promoter. |
| wb | | Cell Signaling Technology rabbit anti-phospho-c-Myc (Thr-58/Ser-62) antibody was used in western blot to study the role of c-Myc glycosylation/phosphorylation in cell. |
SIGMA-ALDRICH search Sigma-Aldrich MYC products
includes other brands or spellings
|
| wb | | Sigma rabbit anti-c-Myc antibody was used in western blot to study the interaction of the 5-HT4R splice variants with SNX27 and NHERF. |
| wb | | Sigma antibody which recognizes c-Myc was used in western blot to study the interation of DnaJ-related factor Mrj with nuclear factor of activated T cells c3 and the transcriptional repression through class II histone deacetylase recruitment mediated by Mrj. |
| wb | | Sigma anti-Myc monoclonal antibody was used in weatern blot to study the neuronal differentiation which Hu and heterogeneous nuclear ribonucleoprotein K involve. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology MYC products
includes other brands or spellings
|
| chip, ip, wb | | Santa Cruz Biotechnology anti-Myc antibody (N-262) was used in immunoprecipitation, western blot and CHIP to human papillomavirus E6 association with Myc proteins in vivo, binding to and cooperatively activating the telomerase reverse transcriptase promoter. |
| ic, ih | | SCBT c-myc antibody was used in immunohistochemistry and immunocytochemistry to investigate the expression of ß-Catenin and c-myc in chronic wounds. |
| ic, ip | | Santa Cruz rabbit anti-c-Myc antibody was used in immunoprecipitation and immunocytochemistry to study the interation of DnaJ-related factor Mrj with nuclear factor of activated T cells c3 and the transcriptional repression through class II histone deacetylase recruitment mediated by Mrj. |
| ic, wb | | Santa Cruz anti-myc (c-Myc 9E10) antibody was used in western blot and immunocytochemistry to study the nuclear function of the intracellular domain of teneurin-2 to repress zic-1-mediated transcription. |
| ih, wb | | Santa Cruz Biotechnologies polyclonal (A-14) and monoclonal (9E10) anti-Myc antibodies were used in western blot to study the GIPC interaction with beta1-adrenergic receptor and its regulation on beta1-adrenergic receptor-mediated ERK activation. |
| ih | | Santa Cruz polyclonal antibody specific for c-Myc was used in immunohistochemistry to study the implications of expression of a panel of oncogenic proteins (Bcl-2, Bcl-6, and c-Myc) and p53 for predicting clinical outcome, particularly overall survival, in immunocompetent individuals with primary CNS DLBCL. |
| ip, wb | | Santa Cruz Biotechnology Myc (9E10) antibody used in western blot and immunoprecipitation to study a novel effector of fibroblast growth factor receptor 3 activation. |
| ip, wb | | SCBT myc 9E10 monoclonal antibody was used in western blot and immunoprecipitation to investigate the binding of BRI2 to APP precursor protein. |
| ip, wb | | SCBT 9E10 anti-myc-tag antibody was used in western blot and immunoprecipitation to investigate the regulatoin of Fbw7-mediated cyclin E proteolysis by Ras. |
| ip | | Santa Cruz Biotechnology mouse anti-c-Myc antibody (C-33) antibody was used in immunoprecipitation to study the role of c-Myc glycosylation/phosphorylation in cell. |
| ip | | SCBT anti-c-Myc (A-14) polyclonal antibody was used in immunoprecipitation to investigate the binding of PTEN to specific PDZ domains. |
| wb | | Santa Cruz Biotechnology monoclonal anti-c-Myc antibody was used in western blot to study HFz6 represses the canonical Wnt pathway by transmitting an antagonistic signaling cascade. |
| wb | | Santa Cruz Biotechnology anti-c-Myc monoclonal antibody was used in western blot to study the regulation of activity of the human tissue factor pathway inhibitor-2 promoter by the ERK/MAPK pathway. |
| wb | | SCBT mouse anti-human c-Myc (C33, SC42) was used in western blot to study the suppression of p53 and c-myc and regulation of apopotosis by fibronectin in human primary cells. |
| wb | | Santa Cruz Biotechnology rabbit polyclonal anti-c-Myc (N-262) antibody was used in western blot to study expression of Mina53 in human colon cancer. |
| wb | | Santa Cruz Biotechnology rabbit polyclonal anti–c-Myc (sc-764) antibody was used in western blot to study expression of Mina53 in in ESCC cell. |
EMD BIOSCIENCES search EMD Biosciences MYC products
includes other brands or spellings
|
| ip | | Oncogene Research Products anti-c-Myc monoclonal antibody (9E10) was used in immunoprecipitation to study Adenomatous Polyposis Coli down-regulation by the ubiquitin-proteasome pathway. |
| wb | | Oncogene mouse anti-human c-Myc (Ab-1, OP10) was used in western blot to study the suppression of p53 and c-myc and regulation of apopotosis by fibronectin in human primary cells. |
| wb | | Oncogene Myc (Ab-1) antibody was used in western blot to study Cdk2-dependent inhibition of p21 stability. |
MILLIPORE search Millipore MYC products
includes other brands or spellings
|
| ih | | Upstate Biotechnology anti-c-Myc antibody was used in immunohistochemistry to study that TIP30 interacts with an Estrogen Receptor alpha-interacting coactivator CIA and regulates c-myc transcription. |
| ip, wb | | Upstate Biotechnologies myc antibody was used in western blot and immunoprecipitation to study COLO-357 cell growth inhibition by TGF beta1. |
INVITROGEN search Invitrogen MYC products
includes other brands or spellings
|
| wb | | Invitrogen anti-myc mouse monoclonal IgG (1:1000) (9E10.2) antibody was used in western blot to study the diversion of nuclear beta-Catenin from TCF. |
THERMO FISHER SCIENTIFIC search Thermo Fisher Scientific MYC products
includes other brands or spellings
|
| wb | | Lab Vision c-myc Ab-5 antibody was tested in western blot by Abminer. |
BECKMAN COULTER search Beckman Coulter MYC products
includes other brands or spellings
|
| ih | | DakoCytomation MYC antibody was tested in immunohistochemistry by HPA (CAB000084) . |
ROCHE APPLIED SCIENCE search Roche Applied Science MYC products
includes other brands or spellings
|
| ic, wb | | Roche Applied Science Myc polyclonal antibody was used in western blot to study HER-2 down-regulation in colon cancer cells. |
| ic, wb | | Roche Molecular Biochemicals anti-Myc antibody 9E10 was used in immunocytochemistry and western blot to study the interaction of the PDZ domain protein PICK1 and the sodium channel bNaC1 and the localization of them at mechanosensory terminals of dorsal root ganglion neurons and dendrites of central neurons. |
| ip, wb | | Roche Diagnostics anti-Myc antibody (9E10) was used in western blot and immunoprecipitation to study the balance between acetylation and methylation of histone H3 lysine 9 on the E2F-responsive dihydrofolate reductase promoter. |
BIOMOL
|
| wb | | Biomol anti-Myc antibody was used in western blot to study Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. |
CAMBRIDGE RESEARCH BIOCHEMICAL
|
| ih | | Cambridge Research Biochemical monoclonal antibody for c-myc (1–6E10) was used in immunohistochemistry to study the biological significance of estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor. |
Articles Reviewed |
| 1. Anne Duggan et al. The PDZ domain protein PICK1 and the sodium channel BNaC1 interact and localize at mechanosensory terminals of dorsal root ganglion neurons and dendrites of central neurons. 2002 |
| 2. Yvonne L Kapila et al. The heparin-binding domain and V region of fibronectin regulate apoptosis by suppression of p53 and c-myc in human primary cells. 2002 |
| 3. Kazuo Kamemura et al. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. 2002 |
| 4. Katsu Ishigaki et al. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer. 2002 |
| 5. Christina Kast et al. The ERK/MAPK pathway regulates the activity of the human tissue factor pathway inhibitor-2 promoter. 2003 |
| 6. Chung-Che Chang et al. Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. 2003 |
| 7. Estelle Nicolas et al. Balance between acetylation and methylation of histone H3 lysine 9 on the E2F-responsive dihydrofolate reductase promoter. 2003 |
| 8. Liaoyuan A Hu et al. GIPC interacts with the beta1-adrenergic receptor and regulates beta1-adrenergic receptor-mediated ERK activation. 2003 |
| 9. Claudia Bagutti et al. The intracellular domain of teneurin-2 has a nuclear function and represses zic-1-mediated transcription. 2003 |
| 10. Tim Veldman et al. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. 2003 |
| 11. Kwesi Teye et al. Increased expression of a Myc target gene Mina53 in human colon cancer. 2004 |
| 12. Tamar Golan et al. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade. 2004 |
| 13. Chao Jiang et al. TIP30 interacts with an estrogen receptor alpha-interacting coactivator CIA and regulates c-myc transcription. 2004 |
| 14. April N Meyer et al. The cytoplasmic tyrosine kinase Pyk2 as a novel effector of fibroblast growth factor receptor 3 activation. 2004 |
| 15. Takashi Suzuki et al. Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor. 2004 |
| 16. Jongkyu Choi et al. Adenomatous polyposis coli is down-regulated by the ubiquitin-proteasome pathway in a process facilitated by Axin. 2004 |
| 17. Lara Joubert et al. New sorting nexin (SNX27) and NHERF specifically interact with the 5-HT4a receptor splice variant: roles in receptor targeting. 2004 |
| 18. Fumihiko Hamada et al. The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF. 2004 |
| 19. Makoto Tsuneoka et al. Mina53 as a potential prognostic factor for esophageal squamous cell carcinoma. 2004 |
| 20. Kohsuke Kanekura et al. A Rac1/phosphatidylinositol 3-kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. 2005 |
| 21. Masato Yano et al. Involvement of Hu and heterogeneous nuclear ribonucleoprotein K in neuronal differentiation through p21 mRNA post-transcriptional regulation. 2005 |
| 22. Scott K Kuwada et al. Integrin alpha5/beta1 expression mediates HER-2 down-regulation in colon cancer cells. 2005 |
| 23. Nichole Boyer Arnold et al. Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein. 2005 |
| 24. Miguel Valiente et al. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. 2005 |
| 25. Hongyan Zhu et al. Cdk2-dependent Inhibition of p21 stability via a C-terminal cyclin-binding motif. 2005 |
| 26. Olivera Stojadinovic et al. Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. 2005 |
| 27. Alex C Minella et al. Ras activity regulates cyclin E degradation by the Fbw7 pathway. 2005 |
| 28. Shuji Matsuda et al. The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production. 2005 |
| 29. Young Ho Koh et al. BACE is degraded via the lysosomal pathway. 2005 |
| 30. Yan-Shan Dai et al. The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment. 2005 |
| 31. Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
| 32. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |